Author

Stavia Turyahabwe

Observed names: S. Turyahabwe, Turyahabwe Stavia, Turyahabwe, Stavia

Institution: Ministry of Health

Observed institutions: Centers for Disease Control and Prevention, United States Department of Defense, Ministry of Health

ORCID: 0000-0002-9537-4448

Observed ORCID: 0000-0002-9537-4448

OpenAlex ID: A5055308699

Impact of socio-economic factors on Tuberculosis treatment outcomes in north-eastern Uganda: a mixed methods study

2021 · Jasper Nidoi, Winters Muttamba, et al. · BMC Public Health · 100

Digital adherence technology for tuberculosis treatment supervision: A stepped-wedge cluster-randomized trial in Uganda

2021 · Adithya Cattamanchi, Rebecca Crowder, et al. · PLoS Medicine · 81

Households experiencing catastrophic costs due to tuberculosis in Uganda: magnitude and cost drivers

2020 · Winters Muttamba, Racheal Tumwebaze, et al. · BMC Public Health · 68

Novel FujiLAM assay to detect tuberculosis in HIV-positive ambulatory patients in four African countries: a diagnostic accuracy study

2022 · Helena Huerga, Mathieu Bastard, et al. · The Lancet Global Health · 66

Multidrug-resistant tuberculosis outbreak associated with poor treatment adherence and delayed treatment: Arua District, Uganda, 2013–2017

2019 · Denis Okethwangu, Doreen Birungi, et al. · BMC Infectious Diseases · 51

Video directly observed therapy for supporting and monitoring adherence to tuberculosis treatment in Uganda: a pilot cohort study

2020 · Juliet N. Sekandi, Esther Buregyeya, et al. · ERJ Open Research · 48

Effectiveness of a community-based approach for the investigation and management of children with household tuberculosis contact in Cameroon and Uganda: a cluster-randomised trial

2023 · Maryline Bonnet, Anca Vasiliu, et al. · The Lancet Global Health · 38

Gender differences among patients with drug resistant tuberculosis and HIV co-infection in Uganda: a countrywide retrospective cohort study

2021 · Joseph Baruch Baluku, David Mukasa, et al. · BMC Infectious Diseases · 38

Iterative Adaptation of a Tuberculosis Digital Medication Adherence Technology to Meet User Needs: Qualitative Study of Patients and Health Care Providers Using Human-Centered Design Methods

2020 · Devika Patel, Christopher Allen Berger, et al. · JMIR Formative Research · 37

Impact of shelter-in-place on TB case notifications and mortality during the COVID-19 pandemic

2020 · J. L. Kadota, T. F. Reza, et al. · The International Journal of Tuberculosis and Lung Disease · 32

Tuberculosis Preventive Treatment Scale-Up Among Antiretroviral Therapy Patients — 16 Countries Supported by the U.S. President’s Emergency Plan for AIDS Relief, 2017–2019

2020 · Michael Melgar, Catherine Nichols, et al. · MMWR Morbidity and Mortality Weekly Report · 28

Ending tuberculosis in a post-COVID-19 world: a person-centred, equity-oriented approach

2022 · Theresa Ryckman, Katherine Robsky, et al. · The Lancet Infectious Diseases · 26

Performance evaluation of Truenat MTB and Truenat MTB-RIF DX assays in comparison to gene XPERT MTB/RIF ultra for the diagnosis of pulmonary tuberculosis in Uganda

2024 · Willy Ssengooba, Achilles Katamba, et al. · BMC Infectious Diseases · 25

Multicomponent strategy with decentralised molecular testing for tuberculosis in Uganda: a cost and cost-effectiveness analysis

2023 · Ryan R Thompson, Talemwa Nalugwa, et al. · The Lancet Global Health · 25

Priority Activities in Child and Adolescent Tuberculosis to Close the Policy-Practice Gap in Low- and Middle-Income Countries

2022 · Karen du Preez, Betina Mendez Alcântara Gabardo, et al. · Pathogens · 25

Implementation science to improve the quality of tuberculosis diagnostic services in Uganda

2019 · Adithya Cattamanchi, Christopher A. Berger, et al. · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · 25

Disability, comorbidities and risk determinants at end of TB treatment in Kenya, Uganda, Zambia and Zimbabwe

2024 · The Kenya, Uganda, Zambia, and Zimbabwe TB Disability Study Group (members listed here in alphabetical order):, S.A. Adakun, et al. · IJTLD OPEN · 22

Association of diabetes, smoking, and alcohol use with subclinical-to-symptomatic spectrum of tuberculosis in 16 countries: an individual participant data meta-analysis of national tuberculosis prevalence surveys

2023 · Yohhei Hamada, Matteo Quartagno, et al. · EClinicalMedicine · 22

Cost and Cost-Effectiveness of a Digital Adherence Technology for Tuberculosis Treatment Support in Uganda

2022 · Ryan R. Thompson, Alex Kityamuwesi, et al. · Value in Health · 22

Implementation of an Effective Decentralised Programme for Detection, Treatment and Prevention of Tuberculosis in Children

2021 · John Dongo, Stephen Graham, et al. · Tropical Medicine and Infectious Disease · 21

Developing a patient-centered community-based model for management of multi-drug resistant tuberculosis in Uganda: a discrete choice experiment

2022 · Rita Makabayi-Mugabe, Joseph Musaazi, et al. · BMC Health Services Research · 19

Addressing the drug-resistant tuberculosis challenge through implementing a mixed model of care in Uganda

2020 · Samuel Kasozi, Nicholas Sebuliba Kirirabwa, et al. · PLoS ONE · 19

Epidemiological profile of patients with rifampicin-resistant tuberculosis: an analysis of the Uganda National Tuberculosis Reference Laboratory Surveillance Data, 2014–2018

2021 · Gloria Bahizi, Robert Kaos Majwala, et al. · Antimicrobial Resistance and Infection Control · 18

Implementation, feasibility, and acceptability of 99DOTS-based supervision of treatment for drug-susceptible TB in Uganda

2023 · Noah Kiwanuka, Alex Kityamuwesi, et al. · PLOS Digital Health · 17

Tuberculosis Preventive Therapy among Persons Living with HIV, Uganda, 2016–2022

2023 · Deus Lukoye, Gail Gustavson, et al. · Emerging infectious diseases · 17

Works count: 140

Citation count: 1,256

H-index: 20

I10-index: 41